Catalent (CTLT) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CTLT Catalent

Watchlist

61.000
+0.250+0.41%

Close Nov 27 16:00 ET

61.000
0.0000.00%

Post 16:25 ET

11.07BMarket Cap-26754P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Wednesday Ends With Index Decline | Wall Street Today
Kevin Travers16:08 ET
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Kevin TraversNov 27 09:57 ET
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Kevin TraversNov 26 16:12 ET
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Seeking AlphaNov 26 14:01 ET
European Equities Close Lower in Tuesday Trading
MT NewswiresNov 26 12:21 ET
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Kevin TraversNov 26 10:02 ET

Comments

Stella-K

Jun 19 04:18

Which gets me RICH faster: Growth ETF vs. Dividend ETF Investing

I've been on the hunt for a low-risk, yet relatively high-yield investment strategy, and I'm sure many of you feel the same. 🤔While I'm hesitant to dive into stocks like $NVIDIA (NVDA.US)$ , fearing the price might be peaking and a sudden drop is imminent, I also find the stable dividends of companies like $Coca-Cola (KO.US)$ underwhelming for my limited capital. 💡 But recently, I stumbled upon the concept of diversified investing, wh...

Moomoo News Global

Mar 4 08:15

Columns Eli Lilly's Donanemab Nears Approval Decision, Could This Be a Turning Point in Alzheimer's Treatment?

The pharma giant $Eli Lilly and Co (LLY.US)$ is on the cusp of a significant breakthrough with its Alzheimer's drug, donanemab. Following the completion of its Phase 3 trials, donanemab is currently undergoing FDA review and has the potential to receive approval later this month. If approved, it would be the second anti-Aβ therapy for Alzheimer's disease to receive full clearance from the U.S. FD...

151364853

Feb 6 12:40

$Catalent (CTLT.US)$ why drop

Bigmoney Dreamer

Feb 5 22:28

$Catalent (CTLT.US)$ 👀63$ all set target

Moomoo Recap US

Feb 5 15:15

Columns Wall Street Today | Stocks Retreat as Fed in No Rush to Cut

RECAP
Stocks Fall as Yields Rise
US stocks fell as yields rose after investors tempered expectations of interest rate cuts this year. Over the weekend, Federal Reserve Chairman Jerome Powell said policymakers are worried that inflation could rear its ugly head and reaccelerate if the central bank moves too soon in lowering borrowing costs.
The $S&P 500 Index (.SPX.US)$ slipped 0.3%, while the tech-heavy $NASDAQ 100 Index (.NDX.US)$ slid 0...